Skip to main content

Table 1 Demographic, ocular and systemic characteristics of the tested subjects

From: Evaluation of ocular pulse amplitude in non-arteritic anterior ischaemic optic neuropathy

 

Study group

Control group

p value

(n = 30 eyes)

(n = 31 eyes)

Mean age (year ± SD)

54.67 ± 10.54

53.39 ± 6.67

0.575

Gender, no. of females (%)

16 (53.3%)

21 (67.7%)

0.249

BMI, mean (SD), kg/m2

29.08 ± 5.23

27.77 ± 4.67

0.304

Hypertension n,(%)

12 (40.0%)

9 (29.0%)

0.367

SBP, mmHg

122,83 ± 13.11

118.71 ± 15.97

0.276

DBP, mmHg

77.70 ± 7.66

75.00 ± 11.25

0.279

Ischaemic heart disease n, (%)

4 (13.3%)

3 (9.7%)

0.707

DM n, (%)

9 (30.0%)

7 (22.6%)

0.510

Hyperlipidemia n, (%)

8 (26.7%)

4 (12.9%)

0.176

BCVA

0.35 ± 0.37

0.96 ± 0.09

<0.001

Spheric equivalant, mean

0.38 ± 1.43

0.47 ± 1.12

0.788

Mean GAT, mmHg ± SD

13.73 ± 2.30

14.84 ± 2.74

0.094

Mean DCT, mmHg ± SD

13.58 ± 1.81

14.20 ± 2.22

0.240

Mean OPA, mmHg ± SD

2.01 ± 0.69

1.97 ± 0.68

0.839

CCT, μm

536.47 ± 35.04

546.61 ± 30.03

0.229

  1. Abbreviations BCVA best-corrected visual acuity, BMI body-mass index, CCT central corneal thickness, DBP diastolic blood pressure, DCT, dynamic contour tonometer, DM diabetes mellitus, GAT Goldmann applanation tonometry, OPA ocular pulse amplitude, SBP systolic blood pressure.